EN
TradingView
Ticker Trading Ideas Educational Ideas Scripts People
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Sign Out Go PRO Go PRO 30-day Free Trial Go PRO Early
Markets US Stocks Health Technology Biotechnology

NUCANA PLC SPON ADR EACH REP 1 ORD SHS
NASDAQ
US Flag
NCNA

NCNA
NUCANA PLC SPON ADR EACH REP 1 ORD SHS
US Flag
NASDAQ
 
Prev
Open
Volume
 — 
Day's Range
Prev
Open
Volume
 — 
Day's Range
Overview
Ideas Technicals

NCNA Stock Chart

Ideas

Videos only
NCNA - Joining Havard Endowment Fund - Buying some here
NCNA, 1D
Long
NCNA: NCNA - Joining Havard Endowment Fund - Buying some here

...

NCNA Bullish Divergence
NCNA, 3D
NCNA: NCNA Bullish Divergence

Looking like a possible buy opportunity. Showing bullish divergence. I'm waiting for the stochastic RSI to cross 20 on the 3 day.

NuCana Announces FDA Clearance to Commence Phase III Study of Ac
NCNA, D
Long
NCNA: NuCana Announces FDA Clearance to Commence Phase III Study of Ac

NCNA: NuCana plc 2019-10-25 07:00:05 NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer

NCNA, Daily
NCNA, 1D
NCNA: NCNA, Daily

waiting for confirmation signe , on 4H frame hammer candle was formed

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —

Profile

Sector: Health Technology
Industry: Biotechnology
Employees: 31
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

News

Community & tools
House rules Moderators People Pine Wizards Chat Brokers Stock Screener Forex Screener Crypto Screener Economic Calendar Shows
For business
Website & broker solutions Widgets Charting solutions Lightweight Charting Library Brokerage integration Advertising Partner program Refer a friend Content streams & RSS
Support
Help Center Pine Script Status page Blog Security vulnerability Contacts
About
How it works Features Pricing Wall of Love Terms of use Disclaimer Privacy policy Cookies policy Careers
© 2020 TradingView
Made with
Select market data provided by ICE Data Services
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out
Go PRO Go PRO 30-day Free Trial Go PRO Early